Market Highlights: Motion sickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by differences in impulses received by the perceived sense of motion by visual senses and the vestibular systemís sense of movement. Various prescription and OTC drugs and products are used to treat motion sickness and provide relief from their symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications. The market study is being classified by Type (Anticholinergic and Antihistamines) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Motion Sickness Treatment are GlaxoSmithKline plc (United Kingdom), Perrigo Company plc (Ireland), Prestige Brands (United States), WellSpring Pharmaceutical Corporation (United States), Caleb Pharmaceuticals (Taiwan), Myungmoon Pharm Co. (South Korea), Baxter International (United States), Reliefband Technologies LLC. (United States) and CVS Health (United States).
Key Questions Answered in the Report What will the Motion Sickness Treatment Market size and the growth rate be in Future? What are the key factors driving the Motion Sickness Treatment Market? What are the key market trends and macro-economic impacting the growth of the Motion Sickness Treatment Market? What are the challenges to market growth? Who are the key vendors in the Motion Sickness Treatment Market? What are the market opportunities and threats faced by the vendors in the Motion Sickness Treatment Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Motion Sickness Treatment Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Motion Sickness Treatment market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Motion Sickness Treatment market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Motion Sickness Treatment Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.